ArticleScientific reports2026
Development and validation of a risk classification integrating the location index to predict renal function after robotic partial nephrectomy.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nephrometry scoring systems are used to predict the surgical complexity of partial nephrectomy (PN) but are insufficient to predict renal function after robotic PN (RPN). The study aimed to calculate a new location factor for predicting postoperative renal function and develop a classification including the location factor. We calculated a location index (L-index) and verified an optimal cutoff value to predict renal function after RPN in 163 patients (development cohort). Then, we developed a new classification with the L-index and validated it in 127 patients (external validation cohort). The primary endpoint was an estimated glomerular filtration rate (eGFR) reduction of ≥ 20% from baseline to 6 months after RPN. This outcome occurred in 24 patients (14.7%) in the development cohort and 28 patients (22.0%) in the external validation cohort. The accuracy for predicting the endpoint was evaluated using area under the receiver operating characteristic curve (AUC). The L-index cutoff values were ≤ 15 and ≤ 30 mm. Using the L-index and tumor volume, we developed the LIVED (L-index and volume for prediction eGFR decline) classification dividing patients into three groups. The classification showed a high AUC compared to other nephrometry scoring systems (AUC = 0.858 vs. 0.674–0.744) in a validation cohort. The LIVED classification integrating the L-index, quantified as a location factor, and tumor volume predicted renal function after RPN with high accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.